Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: a pilot study. Cooperative Group of Study and Treatment of Multiple Myeloma

Ann Oncol. 1996 Jul;7(5):537-8. doi: 10.1093/oxfordjournals.annonc.a010649.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / therapeutic use*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / therapeutic use*
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Pilot Projects
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use*
  • Survival Rate
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Hormonal
  • Prednisone
  • Idarubicin